2019
DOI: 10.4103/joacp.joacp_214_17
|View full text |Cite|
|
Sign up to set email alerts
|

Ambu AuraGain versus intubating laryngeal tube suction as a conduit for endotracheal intubation

Abstract: Background and Aims:Newly developed supraglottic airway devices (SGAs) are designed to be used both for ventilation and as conduits for endotracheal intubation with standard endotracheal tubes (ETTs). We compared the efficacy of the Ambu AuraGain (AAG) and the newly developed intubating laryngeal tube suction disposable (ILTS-D) as conduits for blind and fiber-optically guided endotracheal intubation in an airway mannequin.Material and Methods:This is a prospective, randomized, crossover study in an airway man… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 10 publications
1
0
0
Order By: Relevance
“…The main finding was that the time for successful insertion and the insertion success rate for the Singularity TM Air was significantly inferior compared to the Ambu ® Aura Gain TM . The insertion success rate and the insertion time for the Ambu ® Aura Gain TM laryngeal mask are comparable to those in reported previous mannequin-based studies [21,22]. To date, there are no comparable data for the Singularity TM Air as this is the first controlled trial.…”
Section: Discussionsupporting
confidence: 80%
“…The main finding was that the time for successful insertion and the insertion success rate for the Singularity TM Air was significantly inferior compared to the Ambu ® Aura Gain TM . The insertion success rate and the insertion time for the Ambu ® Aura Gain TM laryngeal mask are comparable to those in reported previous mannequin-based studies [21,22]. To date, there are no comparable data for the Singularity TM Air as this is the first controlled trial.…”
Section: Discussionsupporting
confidence: 80%